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Abstract
Signal recognition particle (SRP) targets proteins to the endoplasmic reticulum (ER). SRP 
recognizes the ribosome synthesizing a signal sequence and delivers it to the SRP receptor (SR) on 
the ER membrane followed by the transfer of the signal sequence to the translocon. Here, we 
present the cryo–electron microscopy structure of the mammalian translating ribosome in complex 
with SRP and SR in a conformation preceding signal sequence handover. The structure visualizes 
all eukaryotic-specific SRP and SR proteins and reveals their roles in stabilizing this conformation 
by forming a large protein assembly at the distal site of SRP RNA. We provide biochemical 
evidence that the guanosine triphosphate hydrolysis of SRP·SR is delayed at this stage, possibly to 
provide a time window for signal sequence handover to the translocon.
In eukaryotes, nascent secretory and membrane proteins are cotranslationally targeted to the 
endoplasmic reticulum (ER) membrane by the universally conserved signal recognition 
particle (SRP) and its receptor (SR) (1–3). SRP recognizes the N-terminal signal sequence 
of the nascent chain on ribosomes synthesizing membrane or secretory proteins (4–6). 
Subsequently, through interactions with the membrane-anchored SR, the ribosome–nascent 
chain complex (RNC) is delivered to the Sec translocon (Sec61p) on the ER membrane (7, 
8).
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The eukaryotic SRP targeting machineries are considerably more complex than their 
bacterial counterparts (9,10). The eukaryotic SRP contains a larger SRP RNA (7SL for 
mammals) composed of S and Alu domains (11) and six eukaryotic proteins (SRP9, SRP14, 
SRP19, SRP54, SRP68, and SRP72) (1), out of which only SRP54 is universally conserved. 
SRP54 binds the ribosomal tunnel exit and the signal sequence through its NG (12) and M 
domains (13), respectively. Eukaryotic SR is a heterodimer of SRα and eukaryotic-specific 
SRβ integrated into the ER membrane (14,15). SRα contains a universally conserved NG 
domain, a flexible linker, and a eukaryotic-specific SRX domain that complexes with SRβ 
(16). The NG domains of SRP54 and SRα interact in a guanosine triphosphate (GTP)–
dependent manner to form the NG heterodimer (17,18), thus delivering translating 
ribosomes to the ER.
By analogy to the bacterial SRP pathway (19,20), it is assumed that the GTP-bound NG 
heterodimer of SRP·SR relocates from the ribosomal tunnel exit to the distal region of the 
SRP RNA where GTP is hydrolyzed. This conformational change might be necessary for the 
attachment and signal sequence handover to the Sec61p translocon (18, 21). Both SRP68 
and SRP72 proteins are likely to be involved in distal site interactions and GTP hydrolysis 
based on their positions on the SRP RNA (18, 22) and because chemical modification of 
these proteins severely represses membrane targeting activity (23). Previous studies also 
suggested roles of the eukaryotic-specific SR components SRX and SRβ in guanosine 
triphosphatase (GTPase) regulation (24) and signal sequence handover to the Sec61p 
translocon (25, 26), respectively. However, the implications of the mechanistic and 
architectural differences between the bacterial and eukaryotic SRP systems have been 
difficult to rationalize. We set out to obtain structural information on the complete 
eukaryotic protein targeting complex on the translating ribosome.
The mammalian SRP·SR·RNC targeting complex was assembled in the presence of 5′-
guanylyl imidodiphosphate (GMPPNP), and its structure was determined using single-
particle cryo–electron microscopy (cryo-EM) at 3.7-Å resolution on average (Fig. 1 and figs. 
S1 and S2). The densities of SRP and SR were resolved around 4.5- to 10-Å resolution (fig. 
S2, C and D), and the SRP RNA is visualized in its entirety (Fig. 1A and fig. S2C). At the 
Alu domain, the SRP RNA and SRP9/14 contact ribosomal subunit interface to arrest 
translation as previously observed (27) (fig. S3, A and B). In the S domain, the ribosomal 
tunnel exit has the density for the SRP54 M domain bound to the signal sequence (Fig. 1B 
and figs. S3, C and D, and S4A) but lacks that for its NG domain (Fig. 1, A and B), 
consistent with previous cryo-EM structures of the SRP·SR·RNC complex (21, 28, 29). 
Instead, a large density is visible at the distal region of the SRP RNA (Fig. 1A), where we 
can dock previously reported crystal structures of SRP and SR proteins (Fig. 1B and figs. S4 
and S5) (18, 22, 30, 31). This structure reveals an architecture of the entire mammalian 
SRP·SR·RNC complex (Fig. 1, B and C).
Compared with the structure of the SRP·RNC complex without the receptor (27), the SRP 
RNA lifts away from the ribosomal tunnel exit by ~12 Å (fig. S6), which would facilitate the 
transfer of the signal sequence to the Sec61p translocon. At the distal site of the SRP RNA, 
the NG heterodimer binds to the SRP RNA at a different angle compared with its bacterial 
counterpart (29) (fig. S7), leading to additional contacts with the SRP RNA, the ribosome, 
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the SRP proteins, and SR (Fig. 2 and fig. S8, A to C). The linker between NG and M 
domains (GM-linker) of SRP54 connecting its NG and M domains, which forms a helix in 
the bacterial complex, is flexibly disposed and is not visible in the map (Fig. 1B and fig. S7). 
The resolution of the SRP RNA at the contact site with the NG heterodimer is ~4.5 Å (fig. 
S2C), resolving the phosphate backbone of the SRP RNA along with a flipped-out base 
stacking with Phe456 of the NG domain of SRα in the GTPase active site (figs. S2D and S9). 
The position of this flipped-out base corresponds to that of the universally conserved G232 
(bacterial G83) (22, 31, 32). The interactions between the SRα NG domain and the SRP 
RNA, including the contacts formed by the flipped-out base and the surrounding helices of 
the NG domain, are similar to the interactions seen for the GTPase-activated bacterial 
complex (32) (figs. S8C and S9). The SRα NG domain also interacts with the SRP68 RBD 
(Fig. 2 and fig. S8C), whereas the extended loop of SRP68 RBD makes contact with the 28S 
ribosomal RNA (rRNA) (fig. S8D).
In the mammalian targeting complex, the NG heterodimer at the SRP RNA distal site is 
locked in position by extensive interactions with SRX·SRβ, which bridges the SRP68 RBD 
and the NG heterodimer (Figs. 1, B and C, and 2, and figs. S4, C and D, and S7). The 
cytosolic domain of SRβ belongs to the Ras GTPase superfamily (14) and forms a 
heterodimer with SRX in the GTP-bound form (33, 34). The interaction interface of SRβ to 
SRX has similarity to the binding site of Ras to its GTPase activator GAP-334, although 
SRX alone does not activate the GTPase of SRβ (30). In the structure of the targeting 
complex, SRα NG further extends the interaction interface of SRβ in a similar manner as 
observed in the structure of the Ras·GAP-334 complex (35) (fig. S10), but, in contrast to 
GAP-334, no elements from either SRX or the SRα NG domain are in direct contact with 
the SRβ-bound GTP (fig. S10). It appears that SRβ does not hydrolyze GTP even in this 
conformation and that GTP-bound SRβ may rather provide the eukaryotic-specific 
stabilizing effect on the NG heterodimer binding at the SRP RNA distal site. Thus, 
SRX·SRβ and SRP68 RBD form a platform to stably dock the NG heterodimer at the distal 
site of SRP RNA to enable signal sequence handover to the Sec61p translocon at the 
exposed ribosomal tunnel exit.
At the distal site of SRP RNA, the SRP72 RBD can be observed extending from the SRP 
RNA to the ribosome surface, where it approaches a hairpin of the ribosomal protein uL3 
(fig. S4F). The C-terminal region of SRP72 RBD was proposed to form an alpha helix (C4 
helix) and mediate interactions with the 28S rRNA (C4 contact) (fig. S11A) (22). However, 
in our map, it appears that the C-terminal region of the SRP72 RBD rather extends toward 
the SRP·SR NG heterodimer interface and interacts with the two stacking residues in the 
GTPase active site, G232 of the SRP RNA and Phe456 of SRα (Fig. 3, A and B, and figs. 
S9A and S11B). Thus, a eukaryotic-specific GTPase regulation mechanism may involve a 
protein component of the SRP (SRP72) in addition to the SRP RNA. To determine whether 
mutations in SRP72 affect the GTPase activity of the targeting complex, we prepared SRP 
variants harboring mutation or deletion in the SRP72 C-terminal region containing the C4 
helix (Arg589-Gln603 based on the human numbering) (fig. S12A). All tested SRP mutants 
were active in translation arrest and membrane targeting in vitro (fig. S13), indicating that 
they were not defective in ribosome interactions. GTPase assays of SRP·SRαβΔTM (lacking 
nonessential luminal and transmembrane regions of SRβ) complexes assembled with the 
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ribosome and signal sequence showed that, unexpectedly, all the SRP variants exhibited 
enhanced GTPase activity compared with wild-type SRP (Fig. 3C and fig. S14). Enhanced 
GTPase activity was also observed when we modified SRP RNA by mutating the flipped-out 
G232 into A (G232A) or by closing the SRP RNA 5f-loop (ΔΔ231, G232U) (Fig. 3D and 
figs. S12B and S14), and the highest GTPase activity was observed by combining the 
mutations on the SRP RNA and SRP72 (Fig. 3D and fig. S14). In addition, an SRX·SRβ–
deletion mutant of SR (SRαΔX) also exhibited a two-fold more enhanced GTPase activity 
than SRαβΔTM (Fig. 3C). Thus, eukaryotic-specific interactions at the SRP RNA distal site 
delay GTP hydrolysis, in contrast to the bacterial system, where distal site interactions 
between SRP RNA and NG heterodimer stimulate GTP hydrolysis (20, 32). The delay of 
GTP hydrolysis by the SRP·SR NG heterodimer at the distal site of the SRP RNA may 
provide a eukaryotic-specific regulatory role. Interestingly, it was reported that the C-
terminal region of SRP72 is cleaved during apoptosis, further supporting its possible role in 
regulating the targeting process (22, 36). We propose that the current structure represents a 
“prehandover” complex of SRP·SR at the SRP RNA distal site, which allows docking of the 
Sec61p translocon onto the exposed ribosomal tunnel exit. Delayed GTP hydrolysis in this 
state might provide a longer time window for the nascent polypeptide to engage the Sec61p 
translocon, which was proposed to be slow in eukaryotic systems (37), before the 
detachment of SRP and SR from RNC. Indeed, the mammalian Sec61p translocon reduces 
the GTPase activity of SRP·SR in the presence of RNC (38).
In conclusion, this study reveals the roles of eukaryotic-specific components of the SRP and 
SR proteins in the mammalian targeting process. This process starts by the recognition of the 
signal sequence by SRP at the exit of the ribosomal tunnel and formation of the SRP54·SRα 
NG heterodimer in the presence of GTP (Fig. 4, A and B). The NG heterodimer then 
relocates to the SRP RNA distal site, where it forms a large complex stabilized by 
interactions with the eukaryotic-specific components of the SRP and SR together with SRP 
RNA (Fig. 4C). At this stage, the GTP hydrolysis of the NG heterodimer is delayed to 
provide a time window for the signal sequence handover from SRP to the Sec61p translocon 
at the exit of the ribosomal tunnel.
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Fig. 1. Architecture of the mammalian SRP·SR·RNC complex.
(A) The cryo-EM map of SRP·SR·RNC complex low-pass filtered to 3.7-Å resolution is 
shown. SRP·SR and ribosomal 40S and 60S subunits are colored magenta, yellow, and light 
blue, respectively. (B) Overall structure model of SRP S domain bound to SR on RNC fitted 
into the map. The cryo-EM map low-pass filtered to 6-Å resolution is colored gray. Models 
are shown in the cartoon. The ribosome and SRP RNA are colored gray and orange, 
respectively. The signal sequence (SS) is colored red, and protein components of SRP and 
SR are colored based on their domain architectures [SRP19, salmon; SRP54 NG, light blue; 
SRP54 M, cyan; SRP68 RNA binding domain (RBD), magenta; SRP68 protein binding 
domain (PBD), light pink; SRP72 PBD, green cyan; SRP72 RBD, limon; SRα SRX, yellow; 
SRα NG, lime; SRβ, wheat]. (C) The structure model of SRP S domain and SR on the RNC 
from two opposite directions. The ribosome and SRP RNA are shown as spheres, and the 
signal sequence and protein components of SRP and SR are shown in the cartoon. Models 
are colored as in Fig. 1B, but bases of SRP RNA are colored light orange. The two 
GMPPNP molecules bound to NG heterodimer and a GTP molecule bound to SRβ are 
shown as red spheres. The positions of these molecules are based on the previous crystal 
structures (PDB ID: 5L3Q and 2FH5) (18, 30). (D) Schematic diagram of SRP and SR (left) 
and the domain architecture of SRP and SR proteins (right). SRP and SR components are 
colored as in Fig. 1B. The interaction between NG domains of SRP54 and SRα is depicted 
in an arrow. In the right panel, regions shown as blank boxes are not modeled in the 
structure. The N terminus of SRβ, shown as a blank box with a dashed line, depicts the 
luminal and transmembrane regions and is not included in the purified construct of SR.
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Fig. 2. Assembly of the NG heterodimer, SRP68 RBD, and SRX·SRβ at the SRP RNA distal site.
(A) Surface representation of the NG heterodimer, SRP68 RBD, SRX·SRβ at the SRP RNA 
distal site from two perpendicular directions. SRP RNA is shown in the cartoon. Other 
components are omitted for clarity. Models are colored as in Fig. 1B. (B and C) The 
interaction between NG heterodimer, SRP68 RBD, and SRX·SRβ. Proteins are shown in the 
cartoon and colored as in Fig. 1B. A GTP molecule bound to SRβ is also shown as in Fig. 
1C. Secondary structure elements of proteins are labeled.
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Fig. 3. The GTPase regulation of mammalian SRP·SR on RNC.
(A) The structure model of the NG heterodimer GTPase active site shown as in Fig. 1C. 
Components other than the NG heterodimer, SRP RNA, SRP72 RBD, and ribosome are 
omitted for clarity. (B) Close-up view of (A). Two GMPPNP molecules, Phe456 of SRα NG, 
and flipped-out G232 of SRP RNA are shown in the stick model. (C) GTPase rate constants 
of the SRP·SR complex formed by wild-type human SRP (hSRP) with SRαβΔTM, SRPs 
bearing indicated SRP72 (h72) mutations with SRαβΔTM, and wild-type SRP with 
SRαΔX. All measurements were carried out with SRP54 fused to a model signal sequence 
and with the 80S ribosome present. The values of kcat were derived using analysis as shown 
in fig. S14. See the supplementary materials for details. (D) GTPase rate constants of the 
SRP·SR complex containing wild-type human SRP and SRPs bearing indicated SRP RNA 
mutations. The last two columns show the GTPase rate constants with SRPs containing 
mutations in both SRP72 (h72) and SRP RNA. All measurements used SRαβΔTM and were 
carried out with SRP54 fused to a model signal sequence and with the 80S ribosome present. 
The values of kcat were derived using analysis as shown in fig. S14. Data were reported as 
mean ± SD, with n = 3 to 6 in (C) and (D).
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Fig. 4. Schematic diagram of the mammalian targeting system.
(A) In the SRP·RNC complex, the SRP54 NG domain occupies the ribosomal tunnel exit. 
SR is anchored to the ER membrane through the transmembrane helix (TM) of SRβ, whose 
cytosolic domain binds the SRX domain of SRα connected to the NG domain through the 
long linker. (B) The SRP54 NG domain initially binds SRα at the ribosomal tunnel exit, 
forming the NG heterodimer in the presence of GTP, which then relocates to the distal site of 
SRP RNA. (C) At the distal site of SRP RNA, SRX-SRβ together with SRP68 RBD 
accommodates the NG heterodimer. The GTPase active site of the NG heterodimer is 
pointed by the red triangle (left panel). The schematic diagram of the GTPase active site 
conformation is shown in the right panel. At this stage, the GTP hydrolysis is delayed by 
SRX·SRβ, SRP72 RBD, and SRP RNA, possibly to keep RNC on the membrane with its 
tunnel exit exposed for the handover of the signal sequence from SRP to the Sec61p 
translocon.
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